As for CLR or lymphocyte to CRP ratio (LCR), the previous studies on surgical tumors (osteosarcoma, gastric cancer, lung cancer, or pancreatic cancer) (29–31) and on infectious events following surgeries (32–34) have demonstrated its effectiveness in providing prognostic information. This evidence concerns the gene CRP and gastric cancer.